MedinCell SA (MDCLF) Ratios
MedinCell SA Ratios
MDCLF's free cash flow for Q4 2026 was $-11.42M. For the 2026 fiscal year, MDCLF's free cash flow was decreased by $-585.00K and operating cash flow was $-10.84M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.67 | 2.70 | 1.66 | 0.34 | 0.89 |
| Quick Ratio | 4.67 | 2.70 | 1.66 | 0.33 | 0.89 |
| Cash Ratio | 3.03 | 1.98 | 1.18 | 0.11 | 0.64 |
| Solvency Ratio | -0.28 | -0.15 | -0.30 | -0.42 | -0.40 |
| Operating Cash Flow Ratio | -1.19 | 0.65 | -0.72 | -0.37 | -0.56 |
| Short-Term Operating Cash Flow Coverage | -9.32 | 2.94 | -2.16 | -0.49 | -0.77 |
| Net Current Asset Value | $ -8.25M | $ -26.20M | $ -50.51M | $ -52.06M | $ -23.60M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.53 | 0.65 | 1.60 | 1.97 | 1.07 |
| Debt-to-Equity Ratio | 18.74 | -3.59 | -1.44 | -1.36 | -3.55 |
| Debt-to-Capital Ratio | 0.95 | 1.39 | 3.25 | 3.74 | 1.39 |
| Long-Term Debt-to-Capital Ratio | 0.94 | 1.50 | 5.20 | -0.38 | 5.65 |
| Financial Leverage Ratio | 35.27 | -5.53 | -0.91 | -0.69 | -3.31 |
| Debt Service Coverage Ratio | -2.04 | -0.97 | -1.85 | -0.57 | -0.72 |
| Interest Coverage Ratio | -3.87 | -2.13 | -4.54 | -6.11 | -12.91 |
| Debt to Market Cap | 0.07 | 0.13 | 0.20 | 0.22 | 0.24 |
| Interest Debt Per Share | 1.78 | 2.19 | 2.24 | 2.45 | 1.98 |
| Net Debt to EBITDA | 0.23 | 0.03 | -2.12 | -1.94 | -1.07 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -130.61% | -51.64% | -221.98% | -282.36% | -561.42% |
| EBITDA Margin | -121.27% | -43.85% | -203.21% | -265.62% | -524.35% |
| Operating Profit Margin | -130.63% | -42.44% | -229.01% | -241.60% | -582.25% |
| Pretax Profit Margin | -185.00% | -71.56% | -272.38% | -321.90% | -606.50% |
| Net Profit Margin | -160.27% | -72.19% | -273.34% | -321.90% | -606.50% |
| Continuous Operations Profit Margin | -160.27% | -72.19% | -273.34% | -321.90% | -606.50% |
| Net Income Per EBT | 86.63% | 100.88% | 100.35% | 100.00% | 100.00% |
| EBT Per EBIT | 141.62% | 168.62% | 118.94% | 133.24% | 104.17% |
| Return on Assets (ROA) | -28.95% | -20.38% | -67.77% | -109.10% | -55.99% |
| Return on Equity (ROE) | -1021.12% | 112.65% | 61.33% | 75.68% | 185.52% |
| Return on Capital Employed (ROCE) | -29.20% | -17.89% | -102.42% | 86.78% | -392.84% |
| Return on Invested Capital (ROIC) | -24.37% | -15.97% | -78.73% | -152.35% | -69.21% |
| Return on Tangible Assets | -29.92% | -21.00% | -72.58% | -116.77% | -58.18% |
| Earnings Yield | -3.87% | -4.40% | -9.04% | -12.95% | -13.44% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.33 | 7.97 | 4.03 | 4.73 | 4.99 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 4.84 | 1.69 | 1.56 | 0.58 |
| Asset Turnover | 0.18 | 0.28 | 0.25 | 0.34 | 0.09 |
| Working Capital Turnover Ratio | 0.31 | 0.83 | -0.69 | -0.48 | 0.21 |
| Cash Conversion Cycle | 84.34 | 45.80 | 90.57 | 77.19 | 73.09 |
| Days of Sales Outstanding | 84.34 | 45.80 | 90.57 | 77.19 | 73.09 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 84.34 | 45.80 | 90.57 | 77.19 | 73.09 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.68 | 0.67 | -0.42 | -0.83 | -0.86 |
| Free Cash Flow Per Share | -0.74 | 0.61 | -0.46 | -0.87 | -0.94 |
| Dividend Paid and CapEx Coverage Ratio | -12.01 | 11.73 | -10.01 | -20.45 | -10.82 |
| Capital Expenditure Coverage Ratio | -12.01 | 11.73 | -10.01 | -20.45 | -10.82 |
| Operating Cash Flow Coverage Ratio | -0.43 | 0.33 | -0.20 | -0.36 | -0.45 |
| Operating Cash Flow to Sales Ratio | -1.26 | 0.76 | -1.30 | -2.11 | -5.22 |
| Free Cash Flow Yield | -3.29% | 4.25% | -4.73% | -8.92% | -12.65% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -25.91 | -22.86 | -11.07 | -7.72 | -7.44 |
| Price-to-Sales (P/S) Ratio | 41.46 | 16.41 | 30.25 | 24.85 | 45.11 |
| Price-to-Book (P/B) Ratio | 264.15 | -25.60 | -6.79 | -5.84 | -13.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -30.43 | 23.54 | -21.13 | -11.22 | -7.91 |
| Price-to-Operating Cash Flow Ratio | -32.96 | 21.53 | -23.24 | -11.76 | -8.64 |
| Price-to-Earnings Growth (PEG) Ratio | -0.68 | 0.80 | 0.36 | -0.29 | -0.46 |
| Enterprise Value Multiple | -33.96 | -37.39 | -17.01 | -11.30 | -9.67 |
| Enterprise Value | 803.99M | 418.77M | 316.59M | 298.34M | 207.38M |
| EV to EBITDA | -33.96 | -37.39 | -17.01 | -11.30 | -9.67 |
| EV to Sales | 41.18 | 16.40 | 34.56 | 30.00 | 50.70 |
| EV to Free Cash Flow | -30.23 | 23.52 | -24.14 | -13.54 | -8.89 |
| EV to Operating Cash Flow | -32.74 | 21.51 | -26.56 | -14.20 | -9.71 |
| Tangible Book Value Per Share | -0.01 | -0.65 | -1.52 | -1.76 | -0.60 |
| Shareholders’ Equity Per Share | 0.09 | -0.56 | -1.44 | -1.68 | -0.54 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | -0.01 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.54 | 0.88 | 0.32 | 0.39 | 0.16 |
| Net Income Per Share | -0.87 | -0.63 | -0.88 | -1.27 | -1.00 |
| Tax Burden | 0.87 | 1.01 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.42 | 1.39 | 1.23 | 1.14 | 1.08 |
| Research & Development to Revenue | 1.36 | 0.95 | 2.30 | 2.81 | 5.77 |
| SG&A to Revenue | 0.95 | 0.02 | 1.00 | 0.72 | 1.52 |
| Stock-Based Compensation to Revenue | 0.00 | 0.12 | 0.31 | 0.23 | 0.59 |
| Income Quality | 0.78 | -1.06 | 0.48 | 0.66 | 0.86 |
Currency in EUR
